Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - remifentanil - powder for concentrate for solution for injection/infusion - 1 milligram(s) - opioid anesthetics; remifentanil

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - remifentanil - powder for concentrate for solution for injection/infusion - 2 milligram(s) - opioid anesthetics; remifentanil

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - remifentanil - powder for concentrate for solution for injection/infusion - 5 milligram(s) - opioid anesthetics; remifentanil

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil hydrochloride (hcl) for injection is indicated for intravenous (iv) administration: - as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. - for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. - as an analgesic component of monitored anesthesia care in adult patients. remifentanil hcl is contraindicated: - for epidural or intrathecal administration due to the presence of glycine in the formulation [see nonclinical toxicology (13)] . - in patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see adverse reactions (6.2)] . risk summary prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to inform a drug-associated risk f

United States - English - NLM (National Library of Medicine)

navinta llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil hydrochloride for injection is indicated for intravenous (iv) administration: - as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. - for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. - as an analgesic component of monitored anesthesia care in adult patients. remifentanil hydrochloride for injection is contraindicated: - for epidural or intrathecal administration due to the presence of glycine in the formulation [see nonclinical toxicology (13)] . - in patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see adverse reactions (6.2)] . prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - remifentanil - powder for concentrate for solution for infusion or injection - remifentanil 1 mg - anesthetics

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - remifentanil - powder for concentrate for solution for infusion or injection - remifentanil 2 mg - anesthetics

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - remifentanil - powder for concentrate for solution for infusion or injection - remifentanil 5 mg - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

as kalceks - alfentanil - solution for injection/infusion - 500 microgram(s)/millilitre - alfentanil

New Zealand - English - Medsafe (Medicines Safety Authority)

medsurge pharma limited - alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml - solution for injection - 1 mg/2ml - active: alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml excipient: sodium chloride sodium hydroxide water for injection - alfentanil injection is indicated in adults and children aged above one year for use as: · an opioid analgesic in general or regional anaesthesia for both short (bolus injections) and long (bolus, supplemented by increments or by continuous infusion) surgical procedures. · an anaesthetic induction agent. due to its rapid and short-lasting action, alfentanil injection is particularly suited as an opioid analgesic for short procedures and outpatient surgery. it is also useful as an analgesic supplement for procedures of medium and long duration, since periods of very painful stimuli can easily be overcome by small increments of alfentanil injection or by adapting its infusion rate.